North America Gene Synthesis Market Size & Outlook
North America gene synthesis market, 2018-2030 (US$M)
Related Markets
North America gene synthesis market highlights
- The North America gene synthesis market generated a revenue of USD 674.8 million in 2022.
- The market is expected to grow at a CAGR of 15.9% from 2023 to 2030.
- In terms of segment, solid-phase synthesis was the largest revenue generating method in 2022.
- PCR-based Enzyme Synthesis is the most lucrative method segment registering the fastest growth during the forecast period.
- Country-wise, U.S. is expected to register the highest CAGR from 2023 to 2030.
North America data book summary
| Market revenue in 2022 | USD 674.8 million |
| Market revenue in 2030 | USD 2,200.9 million |
| Growth rate | 15.9% (CAGR from 2022 to 2030) |
| Largest segment | Solid-phase synthesis |
| Fastest growing segment | PCR-based Enzyme Synthesis |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Solid-phase Synthesis, Chip-based Synthesis, PCR-based Enzyme Synthesis |
| Key market players worldwide | Genscript Biotech Corp Class H, Brooks Automation, Twist Bioscience Corp, ProteoGenix, Biomatik Corporation, Thermo Fisher Scientific Inc, Integrated DNA Technologies, Origene Technologies |
Other key industry trends
- In terms of revenue, North America region accounted for 38.4% of the global gene synthesis market in 2022.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 2,084.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Gene Synthesis Market Scope
Gene Synthesis Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America gene synthesis market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gene synthesis market will help companies and investors design strategic landscapes.
Solid-phase synthesis was the largest segment with a revenue share of 35.66% in 2022. Horizon Databook has segmented the North America gene synthesis market based on solid-phase synthesis, chip-based synthesis, pcr-based enzyme synthesis covering the revenue growth of each sub-segment from 2018 to 2030.
North America dominated the revenue share in 2021. This can be attributed to the presence of several key market participants offering gene synthesis services, increasing interest of major biotechnology & pharmaceutical companies in gene & cell therapy development, expanding field of synthetic biology in the region, and increasing interest of gene synthesis in the molecular biology arena.
Furthermore, presence of high number of Contract Research Organizations (CROs) providing gene synthesis services is also expected to increase the revenue of the region. For instance, GenScript has established a significant presence across the North American region.
It offers a broad range of services, including antibody drug development services and custom gene synthesis services. Furthermore, nonprofit organizations such as BioBricks ensure availability of synthetic biology technologies for humanitarian purposes.
Reasons to subscribe to North America gene synthesis market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America gene synthesis market databook
-
Our clientele includes a mix of gene synthesis market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America gene synthesis market, including forecasts for subscribers. This continent databook contains high-level insights into North America gene synthesis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America gene synthesis market report size, by country, 2018-2030 (US$M)
North America Gene Synthesis Market Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
